// App-Quantinova.ai

TCT-38 : Two-Year Clinical Data Of Cohort 1 And Multi-Modality Imaging Results Up To 1-Year Follow-Up Of The BIOSOLVE-I Study With The Paclitaxel-Eluting Bioabsorbable Magnesium Scaffold (DREAMS)

Researchers

Presenter

  • Michael Haude

Principal Investigators

  • Raimund Erbel

  • Paul Erne

  • Stefan Verheye

  • Paul Vermeersch

  • Hubertus Degen

  • Dirk Boese

  • Ron Waksman

  • Neil Weissman

  • Francesco Prati

  • Jacques Koolen

Medical Centers

  • Luzerner Kantonsspital, Lucerne, Switzerland

  • Cardiovascular Institute Middelheim, Antwerp, Belgium

  • West-German Heart Center Essen, Essen, Germany

  • Rome Heart Research, Rome, Italy

  • Stadtische Kliniken Neuss, Lukaskrankenhaus GmbH

Locations

  • Germany

  • Italy

  • Switzerland

  • Belgium

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Myocardial infarction

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • Nitroglycerin

  • Acetylcholine

  • Paclitaxel

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim